Althea Group Holdings operates in the medicinal cannabis industry in Australia and, through its strategic partnerships and current and prospective regulatory licenses and permits, aims to become a leading and trusted medicinal cannabis brand in Australia.
Althea has been granted all required Office of Drug Control (ODC) licenses including Cultivation, Manufacturing and Export licenses. These licenses, coupled with Althea’s focus on patient care, underpins its business strategy.
Althea has entered into a number of strategic partnerships which has enabled Althea to begin importing and distributing five Althea branded medicinal cannabis products in Australia. Althea Company generated its first sales to pharmacies for supply to eligible patients in Australia in May 2018.
Althea has also developed a complementary education and patient support service through its Althea Concierge mobile application and web-based platform which provides a simple pathway for health care professionals and patients to access information and support to navigate the complexities of accessing and prescribing medicinal cannabis.
Althea Group Holdings has an experienced Board and highly skilled Management with relevant industry experience. Althea Group Holdings’ Board and Management are committed to capitalizing on the growth opportunities that are arising in the medicinal cannabis industry.